Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer
about
Cisplatin-based chemoradiotherapy with 5-fluorouracil or pemetrexed in patients with locally advanced, unresectable esophageal squamous cell carcinoma: A retrospective analysisBiweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation studyConcurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma.External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal CarcinomaPhase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinomaTherapeutic and radiosensitizing effects of armillaridin on human esophageal cancer cells.A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells.Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure patternCocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas.Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.Recent advancements in esophageal cancer treatment in Japan.
P2860
Q33441947-EBD05EA9-8091-439A-BAEE-28E9FACCFB6BQ34204650-0253387D-2A33-45F0-8176-E27DFF3E9F51Q35020568-E9A25E10-DEE9-45FA-A932-66AB4C21B5C5Q35659165-A9AE83AB-D6B3-4648-BF6F-C5A48D5C4BDEQ36104323-42827E02-13AF-492D-BABD-75B6FFA52A37Q36940910-FA279B94-7604-4D4F-8944-60DAD022B67AQ36999366-309F3278-4858-40D2-AB44-F66F360812E7Q37038184-BF0501BA-2AC9-45D1-B82E-DB2BB69DE021Q37142445-518C4E6A-840B-4F2C-8B11-02D5915F58E4Q37250511-FCA139FA-04F9-49EF-8014-34180DBF71E5Q37277133-4768E461-E535-4C92-9988-4CAE73619384Q39157407-AB248D51-C179-4A70-8603-D9985065485BQ42731854-5652F575-C469-41CC-A2E1-9DB9C2AFE9A2Q55658098-EF78F0AA-D98D-4D70-8F5D-064737708185
P2860
Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@ast
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@en
type
label
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@ast
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@en
prefLabel
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@ast
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@en
P2093
P2860
P356
P1476
Phase II trial of docetaxel, c ...... ly advanced oesophageal cancer
@en
P2093
P Del Bianco
R Innocente
R Mazzarotto
V Chiarion-Sileni
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603585
P407
P577
2007-01-23T00:00:00Z